... of gain-of-function alleles on stroke risk. MACE Composite clinical outcomes, often called MACE, were the ... stent thrombosis in patients with ischemic heart disease. MACE Thirty-seven studies reported information on the ability ...

... terminal outcomes (mortality, myocardial infarction, stroke, target revascularization, MACE, and health-related quality-of-life)? Key Points ... because each trial evaluated a different ACS. Combined MACE MACE was reported as a composite outcome in ...

... Figure 3 Mortality Figure 4 Avoidable adverse events (MACE) Figure 5 Avoidable adverse events (repeat cardiac ED ... 49 more) ⨁◯◯◯ VERY LOW CRITICAL Avoidable adverse events (MACE) (follow-up 30 days; assessed with: major adverse ...

... The table below represents the various definitions of MACE used in clinical trials over several years. It ... evident that not only is the definition of MACE not standardized across these clinical trials, but various ...

... troponin T that met inclusion criteria and evaluated MACE with a followup period of greater than 1 ... four studies of troponin T using short-term MACE outcomes following a presentation of suspected ACS ( Table ...

... out that there is no standard definition for MACE (major adverse cardiac events), a commonly used outcome ... that varying definitions of composite endpoints, such as MACE, can lead to substantially different results and conclusions. ...

... catheter aspiration devices versus control on in-hospital MACE Figure 43. Impact of catheter aspiration devices versus control on ≤ 30 day MACE Figure 44. Impact of catheter aspiration devices versus ...

... with regard to short-term and long-term MACE, as well as for the mortality of patients ... Our review lends support toward higher rates of MACE within 1 year in CKD patients with ACS ...

... gain-of-function alleles and reduced risk of MACE (composite). The strength of these findings is limited ... the association of loss-of-function alleles with MACE and stent thrombosis under these alternative models were ...

... consistent difference from usual care in effects on MACE, cardiac mortality, all-cause mortality, repeat ACS, revascularization, ... enhanced care and usual care arms. Other than MACE, adverse effects were not reported for any other ...